These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 33550957)

  • 1. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
    Cui F; Luo P; Bai Y; Meng J
    Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
    Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S
    Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
    Fu J; Cai H; Wu Y; Fang S; Wang D
    Gene; 2020 Sep; 755():144886. PubMed ID: 32534055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1.
    Fan Y; Li H; Yu Z; Dong W; Cui X; Ma J; Li S
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31919528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).
    Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y
    Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
    Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM
    Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overexpression of lncRNA FEZF1-AS1 promotes progression of non-small cell lung cancer
    Li F; Xiang J; Liu J; Wang X; Jiang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):841-850. PubMed ID: 38862441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
    Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
    Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma.
    Zhang N; Shen H; Huang S; Wang F; Liu H; Xie F; Jiang L; Chen X
    Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34783233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p.
    Shen D; Li J; Tao K; Jiang Y
    Bioengineered; 2021 Dec; 12(1):3525-3538. PubMed ID: 34346845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1.
    Cheng G; Li Y; Liu Z; Song X
    Adv Clin Exp Med; 2021 Oct; 30(10):1043-1050. PubMed ID: 34610219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
    Zhang G; An X; Zhao H; Zhang Q; Zhao H
    Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
    Yang Y; Dong MH; Hu HM; Min QH; Xiao L
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.